Agentix Corp. SEC filings AGTX
Agentix Corp. has 153 filings in SEC EDGAR's recent list, going back to Apr 1, 2014. Its latest annual report, Form 10-K, was filed on Jul 1, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 14, 2022 (officer or director change). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Aug 15, 2025 | Jun 30, 2025 |
| NT 10-K | Form nt 10-k | Jul 1, 2025 | Mar 31, 2025 |
| NT 10-Q | Filing | Feb 14, 2025 | Dec 31, 2024 |
| NT 10-Q | Filing | Nov 14, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Aug 15, 2024 | Jun 30, 2024 |
| NT 10-K | Filing | Jul 1, 2024 | Mar 31, 2024 |
| NT 10-Q | Filing | Nov 14, 2023 | Sep 30, 2023 |
| NT 10-Q | Filing | Aug 14, 2023 | Jun 30, 2023 |
| NT 10-K | Filing | Jun 29, 2023 | Mar 31, 2023 |
| NT 10-K | Filing | Jun 30, 2022 | Mar 31, 2022 |
| RW | Filing | Mar 11, 2022 | — |
| D | Filing | Feb 11, 2021 | — |
| EFFECT | Filing | Dec 23, 2020 | — |
| CORRESP | Letter to the SEC | Dec 11, 2020 | — |
| NT 10-K | Filing | Nov 30, 2020 | Aug 31, 2020 |
| UPLOAD | Letter from the SEC | Nov 13, 2020 | — |
| EFFECT | Filing | Sep 23, 2020 | — |
| CORRESP | Letter to the SEC | Sep 18, 2020 | — |
| CORRESP | Letter to the SEC | Sep 17, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2020 | — |
| CORRESP | Letter to the SEC | Sep 15, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2020 | — |
| NT 10-Q | Form 10-q | Apr 14, 2020 | Feb 29, 2020 |
| NT 10-K | Filing | Dec 3, 2019 | Aug 31, 2019 |
| NT 10-Q | Filing | Jan 15, 2019 | Nov 30, 2018 |
| NT 10-Q | Filing | Jul 17, 2018 | May 31, 2018 |
| NT 10-K | Filing | Nov 30, 2017 | Aug 31, 2017 |
| NT 10-Q | Filing | Jul 17, 2017 | May 31, 2017 |
| NT 10-Q | Filing | Jan 17, 2017 | Nov 30, 2016 |
| NT 10-K | Filing | Nov 30, 2016 | Aug 31, 2016 |
| NT 10-Q | Filing | Jul 18, 2016 | May 31, 2016 |
| NT 10-K | Filing | Dec 1, 2015 | Aug 31, 2015 |
| NT 10-Q | Filing | Jul 16, 2015 | May 31, 2015 |
| EFFECT | Filing | Apr 20, 2015 | — |
| NT 10-Q | Filing | Apr 14, 2015 | Feb 28, 2015 |
| D | Filing | Apr 2, 2015 | — |
| 8-A12G | Filing | Feb 24, 2015 | — |
| EFFECT | Filing | Jan 12, 2015 | — |
| CORRESP | Letter to the SEC | Jan 9, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2014 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AGTX (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Dana Point, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1603345
- Former names
- FairWind Energy Inc. (until Jun 27, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.